Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199374 · ClinicalTrials.gov registry record · NA
PARCA (a Digital Tool) to Improve Justice and Health
A NA study of Behavioral Addiction, sponsored by George Mason University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT07199374: Recruiting NA study of Behavioral Addiction, sponsored by George Mason University.
NCT07199374 is a NA study of Behavioral Addiction that is actively recruiting participants, run by George Mason University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07199374, a NA study of Behavioral Addiction, is actively recruiting participants, sponsored by George Mason University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to conduct surveys and interviews aimed to gain a better understanding of ways to improve the substance use treatment process, connections between clients and officers, and goal selection and achievement for clients using the PARCA app
Primary Outcome
This represents the number of days that the individual starts treatment based on the day that they started supervision. This can be measured in the supervision records. This is an event in the record system like an electronic health record.
Conditions Studied
Interventions
- BEHAVIORAL PARCA
Study Locations (2)
Texas
- Travis County Community Services - Austin
- Dallas County Community Supervision - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT07199374 shows while recruiting
NCT07199374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Behavioral Addiction appearing as the primary indexed condition, and to 1 intervention - of which PARCA is the first listed.
NCT07199374 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07199374 about?
NCT07199374 is a clinical study titled "PARCA (a Digital Tool) to Improve Justice and Health". The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to condu...
What is the current status of trial NCT07199374?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-03-01. Estimated completion is 2027-05.
What conditions does trial NCT07199374 study?
This clinical trial studies the following conditions: Behavioral Addiction.
What interventions are being tested in trial NCT07199374?
The interventions under investigation include: PARCA (BEHAVIORAL).
Who is sponsoring clinical trial NCT07199374?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199374 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07199374's enrollment target sits among peer trials
50 1280th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI